Highlights AcuCort AB

Equities

ACUC

SE0009695927

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 21/05/2024 am IST			5-day change	1st Jan Change
0.766 ^SEK	+3.51%		+45.08%	+84.58%

26/04	AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	AcuCort AB Provides Update on Phase IV Study ZEQ001	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
AcuCort AB Provides Update on Phase IV Study ZEQ001	16/04	CI
AcuCort AB Announces Update on FDA Application Ahead of Launch in the USA	07/03	CI
Acucort Lands First Zeqmelit Order from Unimedic Pharma	27/02	MT
AcuCort AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02	CI
AcuCort AB Announces First Patient Using Zeqmelit in Study Ahead of Market Launch	31/01	CI
AcuCort’s Oral Film Gains 10-year Trademark Protection in Switzerland	29/01	MT
AcuCort Secures Trademark Protection for Zeqmelit in India	26/01	MT
AcuCort AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	30/11	CI
AcuCort AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31	CI
Acucort AB Signs Partnership Agreement for the Four Major Nordic Countries with Unimedic Pharma	31/23/31	CI
AcuCort Receives Ethics Approval for Study with ZeqmelitÂ®	04/23/04	CI
Acucort Receives Patent for Oral Film in Brazil	31/23/31	CI
AcuCort AB Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28	CI
AcuCort AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	24/23/24	CI
Fda Requests Additional Information Prior to Acucort's Registration Application in the United States	20/23/20	CI
AcuCort Submitted the Price and Subsidy Application to TLV Regarding Zeqmelit®	24/23/24	CI
Acucort Receives Market Approval from the Finnish Medicines Agency for the Drug Zeqmelit	24/23/24	CI
AcuCort AB Signs Exclusive Commercial Agreement with Kamada Ltd	23/22/23	CI
AcuCort AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AcuCort AB

Equities

ACUC

SE0009695927

Highlights

Filters